Keyphrases
Protein Kinase
100%
Cisplatin
21%
Tumor Necrosis Factor-α
18%
Cis-diamminedichloroplatinum
18%
Induced Cell Death
18%
Cell Death
17%
Breast Cancer
17%
Apoptosis
15%
Breast Cancer Cells
15%
MCF-7 Cells
15%
Glucocerebrosidase
14%
S6 Kinase 1 (S6K1)
13%
Autophagy
13%
Cisplatin-induced
12%
HeLa Cells
11%
DNA Damage-induced Apoptosis
11%
Overexpression
10%
Knockdown
10%
Metallothionein
10%
Cisplatin Resistance
9%
Glucosidase
9%
Heat-stable
9%
Lyngbyatoxin
9%
Stable Factor
9%
DNA Damage
8%
Induced Apoptosis
8%
Rat Liver
8%
Protein Kinase C Isozymes
8%
Phorbol 12
7%
Rottlerin
7%
Bryostatin
7%
Mammalian Target of Rapamycin (mTOR)
7%
Indolactam
6%
Caspase
6%
Cellular Sensitivity
6%
HeLa
6%
Signal Transduction Pathway
6%
Caspase Activation
6%
Cancer Cells
6%
Anti-apoptotic
6%
Anticancer Drugs
6%
Cell Survival
6%
Bcl-2 Family Proteins
6%
B-cell Lymphoma 2 (Bcl-2)
5%
In Cancer
5%
Small Cell Lung Cancer
5%
Oncogene
5%
Cancer Therapy
5%
Proteolytic Activation
5%
Cancer Cell Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Kinase C
66%
Cisplatin
42%
Breast Cancer
15%
Tumor Necrosis Factor
13%
Malignant Neoplasm
13%
Glucosylceramidase
11%
Metallothionein
10%
Anticarcinogen
9%
Glucosidase
9%
Lyngbyatoxin-A
9%
Blood Clotting Factor 7
8%
Antiapoptotic
7%
Phosphatidylserine
7%
Indolactam V
7%
Protein Kinase C Activator
7%
Phorbol 12,13-dibutyrate
7%
S6 Kinase
6%
Rottlerin
6%
Bryostatin 1
6%
Caspase
6%
Phospholipid
5%
Small Cell Lung Cancer
5%
Uterine Cervix Carcinoma
5%
Neoplasm
5%
Biochemistry, Genetics and Molecular Biology
Protein Kinase C
64%
Cancer Cell
21%
Cell Death
18%
Tumor Necrosis Factor
18%
Cisplatin
13%
Downregulation
12%
Autophagy
11%
Phosphotransferase
11%
Kinase
11%
DNA Damage
10%
Cell Survival
10%
Isoform
9%
Signal Transduction
8%
Hydrolase
6%
Glucosylceramidase
6%
Glucocerebrosidase
6%
P53
6%
Mammalian Target of Rapamycin
6%
Oncogene
5%
Rottlerin
5%
Caspase
5%
